Dyne Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DYN and other ETFs, options, and stocks.

About DYN

Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph.

CEO

John G. Cox

CEOJohn G. Cox

Employees

191

Employees191

Headquarters

Waltham, Massachusetts

HeadquartersWaltham, Massachusetts

Founded

2017

Founded2017

Employees

191

Employees191

DYN Key Statistics

Market cap

983.22M

Market cap983.22M

Price-Earnings ratio

-2.42

Price-Earnings ratio-2.42

Dividend yield

—

Dividend yield—

Average volume

3.63M

Average volume3.63M

High today

$9.52

High today$9.52

Low today

$8.30

Low today$8.30

Open price

$8.74

Open price$8.74

Volume

9.32M

Volume9.32M

52 Week high

$47.45

52 Week high$47.45

52 Week low

$6.36

52 Week low$6.36

Analyst ratings

88%

of 17 ratings

Buy

88.2%

Hold

11.8%

Sell

People also own

Based on the portfolios of people who own DYN. This list is generated using Robinhood data, and it’s not a recommendation.